General Information of Drug Transporter (DT)
DT ID DTD0130 Transporter Info
Gene Name SLC1A2
Transporter Name Excitatory amino acid transporter 2
Gene ID
6506
UniProt ID
P43004
Epigenetic Regulations of This DT (EGR)

Methylation

  Pancretic ductal adenocarcinoma

         16 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

5'UTR (cg06482428)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.90E+00 Statistic Test p-value: 8.23E-22; Z-score: 3.45E+00

Methylation in Case

4.55E-01 (Median) Methylation in Control 2.40E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS1500 (cg10844844)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.15E+00 Statistic Test p-value: 7.99E-04; Z-score: -5.52E-01

Methylation in Case

1.35E-01 (Median) Methylation in Control 1.55E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS1500 (cg02196227)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 9.64E-03; Z-score: 8.67E-01

Methylation in Case

8.32E-02 (Median) Methylation in Control 6.89E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg18440902)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.91E+00 Statistic Test p-value: 2.33E-21; Z-score: 5.47E+00

Methylation in Case

1.52E-01 (Median) Methylation in Control 7.93E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg20786061)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 7.83E-04; Z-score: -7.54E-01

Methylation in Case

6.04E-02 (Median) Methylation in Control 6.52E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

TSS200 (cg19556774)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.65E-02; Z-score: 1.44E-01

Methylation in Case

4.27E-01 (Median) Methylation in Control 4.15E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

1stExon (cg15668691)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 1.48E-05; Z-score: 8.20E-01

Methylation in Case

8.74E-01 (Median) Methylation in Control 8.33E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg19521693)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 1.04E-20; Z-score: -3.09E+00

Methylation in Case

3.06E-01 (Median) Methylation in Control 4.10E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg04994795)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 9.39E-16; Z-score: -2.26E+00

Methylation in Case

4.59E-01 (Median) Methylation in Control 6.15E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg24712501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 7.18E-08; Z-score: -1.13E+00

Methylation in Case

4.30E-01 (Median) Methylation in Control 4.80E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg11624345)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 7.05E-07; Z-score: 1.66E+00

Methylation in Case

5.50E-01 (Median) Methylation in Control 4.11E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg10238725)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 6.42E-06; Z-score: -9.19E-01

Methylation in Case

7.27E-01 (Median) Methylation in Control 7.69E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg23093692)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 2.67E-03; Z-score: -1.02E+00

Methylation in Case

6.86E-01 (Median) Methylation in Control 7.76E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg19538722)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 6.07E-03; Z-score: -3.84E-01

Methylation in Case

9.69E-02 (Median) Methylation in Control 1.06E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg23529278)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 1.71E-02; Z-score: 8.86E-01

Methylation in Case

9.01E-01 (Median) Methylation in Control 8.54E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC1A2 in pancretic ductal adenocarcinoma [ 1 ]

Location

3'UTR (cg15310871)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.64E-05; Z-score: -9.83E-01

Methylation in Case

8.13E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Bladder cancer

         23 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS1500 (cg25963980)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.77E+00 Statistic Test p-value: 3.15E-08; Z-score: -1.69E+01

Methylation in Case

3.03E-01 (Median) Methylation in Control 5.37E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS1500 (cg08258650)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.69E+00 Statistic Test p-value: 2.24E-06; Z-score: -6.44E+00

Methylation in Case

8.33E-02 (Median) Methylation in Control 3.08E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS1500 (cg10159951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.24E+00 Statistic Test p-value: 1.31E-04; Z-score: -4.33E+00

Methylation in Case

1.09E-01 (Median) Methylation in Control 3.52E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS1500 (cg21163960)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -4.14E+00 Statistic Test p-value: 3.08E-03; Z-score: -2.54E+00

Methylation in Case

6.42E-02 (Median) Methylation in Control 2.66E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS1500 (cg15562780)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 8.28E-03; Z-score: 2.40E+00

Methylation in Case

1.13E-01 (Median) Methylation in Control 1.01E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS1500 (cg24634422)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.02E+00 Statistic Test p-value: 2.33E-02; Z-score: -2.14E+00

Methylation in Case

7.48E-02 (Median) Methylation in Control 1.51E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

TSS200 (cg07724977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.07E+00 Statistic Test p-value: 2.77E-03; Z-score: 1.70E+00

Methylation in Case

4.91E-02 (Median) Methylation in Control 2.37E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg21895324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.70E+00 Statistic Test p-value: 1.19E-11; Z-score: -1.02E+01

Methylation in Case

2.26E-01 (Median) Methylation in Control 6.11E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg19653967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.60E+00 Statistic Test p-value: 8.91E-08; Z-score: -5.54E+00

Methylation in Case

3.62E-01 (Median) Methylation in Control 5.78E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg10331829)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.33E+00 Statistic Test p-value: 2.74E-07; Z-score: -6.12E+00

Methylation in Case

2.69E-01 (Median) Methylation in Control 6.26E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg13844463)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.61E+00 Statistic Test p-value: 9.23E-07; Z-score: -7.23E+00

Methylation in Case

1.48E-01 (Median) Methylation in Control 5.34E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg14746605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 9.19E-05; Z-score: -4.27E+00

Methylation in Case

8.31E-01 (Median) Methylation in Control 8.96E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg27457284)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.00E+00 Statistic Test p-value: 5.01E-04; Z-score: -2.92E+00

Methylation in Case

1.52E-01 (Median) Methylation in Control 3.04E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg13971030)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.63E+00 Statistic Test p-value: 1.31E-03; Z-score: 3.53E+00

Methylation in Case

8.24E-01 (Median) Methylation in Control 5.07E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg19112204)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 1.69E-03; Z-score: -3.12E+00

Methylation in Case

5.23E-01 (Median) Methylation in Control 7.69E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 4.53E-03; Z-score: 2.24E+00

Methylation in Case

7.48E-01 (Median) Methylation in Control 6.14E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg22934516)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.30E+00 Statistic Test p-value: 5.39E-03; Z-score: 1.72E+00

Methylation in Case

7.52E-02 (Median) Methylation in Control 5.77E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg24944109)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.64E+00 Statistic Test p-value: 6.40E-03; Z-score: -1.80E+00

Methylation in Case

1.44E-01 (Median) Methylation in Control 2.37E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg23501962)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.32E+00 Statistic Test p-value: 1.16E-02; Z-score: -1.28E+00

Methylation in Case

1.93E-01 (Median) Methylation in Control 2.56E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 20

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg24183324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.14E+00 Statistic Test p-value: 1.20E-02; Z-score: -1.55E+00

Methylation in Case

1.06E-01 (Median) Methylation in Control 2.27E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 21

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg25961618)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.24E-02; Z-score: -1.94E+00

Methylation in Case

7.66E-01 (Median) Methylation in Control 8.00E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 22

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

Body (cg08411235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 2.81E-02; Z-score: -1.81E+00

Methylation in Case

2.66E-01 (Median) Methylation in Control 3.33E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 23

Methylation of SLC1A2 in bladder cancer [ 2 ]

Location

3'UTR (cg26635576)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 7.08E-03; Z-score: -2.33E+00

Methylation in Case

8.61E-01 (Median) Methylation in Control 9.04E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         21 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg25963980)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.36E+00 Statistic Test p-value: 3.10E-08; Z-score: -1.79E+00

Methylation in Case

4.51E-01 (Median) Methylation in Control 6.12E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg24634422)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.37E+00 Statistic Test p-value: 4.88E-07; Z-score: 9.35E-01

Methylation in Case

6.12E-02 (Median) Methylation in Control 4.45E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg10159951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.28E+00 Statistic Test p-value: 9.64E-05; Z-score: 6.80E-01

Methylation in Case

1.54E-01 (Median) Methylation in Control 1.20E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg21163960)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.95E+00 Statistic Test p-value: 2.77E-04; Z-score: 1.29E+00

Methylation in Case

1.39E-01 (Median) Methylation in Control 7.16E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg18494399)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.41E+00 Statistic Test p-value: 4.69E-04; Z-score: 3.04E-01

Methylation in Case

2.23E-02 (Median) Methylation in Control 1.58E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg08258650)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 4.30E-03; Z-score: 5.30E-02

Methylation in Case

1.17E-01 (Median) Methylation in Control 1.15E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS1500 (cg15562780)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 3.79E-02; Z-score: 3.24E-02

Methylation in Case

8.77E-02 (Median) Methylation in Control 8.69E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS200 (cg07724977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.80E+00 Statistic Test p-value: 1.76E-07; Z-score: -1.05E+00

Methylation in Case

1.64E-02 (Median) Methylation in Control 4.60E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS200 (cg17754876)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.20E-02; Z-score: -3.15E-01

Methylation in Case

1.11E-01 (Median) Methylation in Control 1.19E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

TSS200 (cg25230151)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 2.59E-02; Z-score: -3.21E-01

Methylation in Case

1.48E-02 (Median) Methylation in Control 1.81E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg23501962)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.70E+00 Statistic Test p-value: 5.09E-17; Z-score: -2.35E+00

Methylation in Case

1.71E-01 (Median) Methylation in Control 2.90E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg24183324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.95E+00 Statistic Test p-value: 1.14E-15; Z-score: -2.22E+00

Methylation in Case

1.29E-01 (Median) Methylation in Control 2.52E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg19112204)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 2.69E-15; Z-score: -2.77E+00

Methylation in Case

4.97E-01 (Median) Methylation in Control 6.64E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg24944109)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.82E+00 Statistic Test p-value: 2.16E-11; Z-score: -1.49E+00

Methylation in Case

1.09E-01 (Median) Methylation in Control 1.98E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.27E+00 Statistic Test p-value: 1.92E-07; Z-score: 1.64E+00

Methylation in Case

5.77E-01 (Median) Methylation in Control 4.54E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg27457284)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.13E+00 Statistic Test p-value: 2.10E-07; Z-score: -1.40E+00

Methylation in Case

1.32E-01 (Median) Methylation in Control 2.82E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg14746605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.48E-05; Z-score: -6.74E-01

Methylation in Case

8.71E-01 (Median) Methylation in Control 8.88E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg19653967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 6.46E-04; Z-score: -7.90E-01

Methylation in Case

4.80E-01 (Median) Methylation in Control 5.26E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg13844463)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 4.43E-03; Z-score: -1.04E+00

Methylation in Case

3.36E-01 (Median) Methylation in Control 3.95E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 20

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

Body (cg20740024)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 3.89E-02; Z-score: 2.89E-01

Methylation in Case

8.35E-01 (Median) Methylation in Control 8.07E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 21

Methylation of SLC1A2 in breast cancer [ 3 ]

Location

3'UTR (cg25475999)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.94E-02; Z-score: -3.71E-01

Methylation in Case

7.41E-01 (Median) Methylation in Control 7.88E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg18494399)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.47E+00 Statistic Test p-value: 1.38E-04; Z-score: 1.91E+00

Methylation in Case

2.45E-02 (Median) Methylation in Control 1.67E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg10159951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.03E+00 Statistic Test p-value: 5.23E-04; Z-score: 2.48E+00

Methylation in Case

5.19E-02 (Median) Methylation in Control 2.56E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg24634422)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.94E+00 Statistic Test p-value: 7.81E-04; Z-score: 1.11E+00

Methylation in Case

2.44E-02 (Median) Methylation in Control 1.26E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg08258650)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.56E+00 Statistic Test p-value: 1.19E-03; Z-score: 1.27E+00

Methylation in Case

3.22E-02 (Median) Methylation in Control 2.07E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS1500 (cg21163960)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 2.40E-02; Z-score: 1.00E+00

Methylation in Case

4.02E-02 (Median) Methylation in Control 3.59E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS200 (cg17754876)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 6.98E-04; Z-score: 1.67E+00

Methylation in Case

8.07E-02 (Median) Methylation in Control 5.70E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS200 (cg25230151)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 2.52E-02; Z-score: 7.89E-01

Methylation in Case

1.47E-02 (Median) Methylation in Control 1.31E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

TSS200 (cg07724977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.20E+00 Statistic Test p-value: 3.16E-02; Z-score: 4.05E-01

Methylation in Case

2.69E-02 (Median) Methylation in Control 2.25E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg23501962)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.93E+00 Statistic Test p-value: 1.16E-06; Z-score: 1.67E+00

Methylation in Case

2.21E-01 (Median) Methylation in Control 1.15E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg24944109)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.70E+00 Statistic Test p-value: 1.82E-05; Z-score: 1.45E+00

Methylation in Case

1.46E-01 (Median) Methylation in Control 8.58E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg24183324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.70E+00 Statistic Test p-value: 2.53E-05; Z-score: 1.24E+00

Methylation in Case

1.31E-01 (Median) Methylation in Control 7.74E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg27457284)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.55E+00 Statistic Test p-value: 3.22E-05; Z-score: 1.56E+00

Methylation in Case

2.41E-01 (Median) Methylation in Control 1.55E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colon cancer

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg07744841)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.49E+00 Statistic Test p-value: 1.41E-06; Z-score: 2.21E+00

Methylation in Case

6.01E-01 (Median) Methylation in Control 4.04E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg25468058)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 1.15E-05; Z-score: -6.18E+00

Methylation in Case

7.32E-01 (Median) Methylation in Control 8.50E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg09360041)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.24E+00 Statistic Test p-value: 1.66E-05; Z-score: -3.40E+00

Methylation in Case

6.34E-01 (Median) Methylation in Control 7.85E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg17445913)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.88E+00 Statistic Test p-value: 1.55E-04; Z-score: 4.19E+00

Methylation in Case

3.67E-01 (Median) Methylation in Control 1.95E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg15932136)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.20E+00 Statistic Test p-value: 3.49E-03; Z-score: -2.12E+00

Methylation in Case

3.56E-01 (Median) Methylation in Control 4.28E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS1500 (cg18646365)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.25E+00 Statistic Test p-value: 4.55E-03; Z-score: 1.55E+00

Methylation in Case

5.46E-01 (Median) Methylation in Control 4.38E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

TSS200 (cg08288703)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 1.35E-05; Z-score: -1.77E+00

Methylation in Case

3.45E-01 (Median) Methylation in Control 4.31E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

1stExon (cg15726426)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 1.48E-04; Z-score: 1.19E+00

Methylation in Case

5.91E-01 (Median) Methylation in Control 5.27E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

Body (cg23947050)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 3.99E-05; Z-score: -4.04E+00

Methylation in Case

6.29E-01 (Median) Methylation in Control 7.94E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

Body (cg05701706)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 1.19E-04; Z-score: 1.28E+00

Methylation in Case

8.60E-01 (Median) Methylation in Control 8.24E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

Body (cg10156714)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 2.21E-04; Z-score: -2.21E+00

Methylation in Case

7.38E-01 (Median) Methylation in Control 8.14E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in colon adenocarcinoma [ 5 ]

Location

Body (cg00551954)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 3.55E-03; Z-score: 1.06E+00

Methylation in Case

8.35E-01 (Median) Methylation in Control 8.12E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         21 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg24634422)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.13E+00 Statistic Test p-value: 2.57E-11; Z-score: 1.08E+01

Methylation in Case

3.20E-01 (Median) Methylation in Control 1.02E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg15562780)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.29E+00 Statistic Test p-value: 8.21E-10; Z-score: 5.64E+00

Methylation in Case

3.38E-01 (Median) Methylation in Control 1.47E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg18494399)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 5.34E+00 Statistic Test p-value: 1.52E-09; Z-score: 1.09E+01

Methylation in Case

1.34E-01 (Median) Methylation in Control 2.51E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg10159951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.57E+00 Statistic Test p-value: 1.02E-06; Z-score: 1.44E+00

Methylation in Case

2.40E-01 (Median) Methylation in Control 1.53E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg08258650)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.32E+00 Statistic Test p-value: 6.29E-05; Z-score: 9.64E-01

Methylation in Case

1.83E-01 (Median) Methylation in Control 1.38E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg21163960)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 1.04E-04; Z-score: 2.64E-01

Methylation in Case

1.03E-01 (Median) Methylation in Control 9.10E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS1500 (cg25963980)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 8.40E-04; Z-score: 1.30E+00

Methylation in Case

5.76E-01 (Median) Methylation in Control 5.10E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS200 (cg17754876)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.14E+00 Statistic Test p-value: 6.05E-07; Z-score: 8.28E-01

Methylation in Case

1.67E-01 (Median) Methylation in Control 1.47E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS200 (cg07724977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.32E+00 Statistic Test p-value: 8.08E-07; Z-score: 8.83E-01

Methylation in Case

4.19E-02 (Median) Methylation in Control 3.17E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

TSS200 (cg25230151)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.30E+00 Statistic Test p-value: 1.66E-06; Z-score: 1.23E+00

Methylation in Case

2.09E-02 (Median) Methylation in Control 1.60E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg24944109)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.58E+00 Statistic Test p-value: 3.41E-10; Z-score: 4.39E+00

Methylation in Case

3.40E-01 (Median) Methylation in Control 2.16E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg27457284)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.72E+00 Statistic Test p-value: 1.35E-07; Z-score: 2.34E+00

Methylation in Case

2.22E-01 (Median) Methylation in Control 1.30E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 1.89E-07; Z-score: -2.02E+00

Methylation in Case

7.71E-01 (Median) Methylation in Control 8.49E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg23501962)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 1.89E-07; Z-score: 1.97E+00

Methylation in Case

3.40E-01 (Median) Methylation in Control 2.56E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg24183324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.45E+00 Statistic Test p-value: 3.07E-07; Z-score: 1.69E+00

Methylation in Case

1.61E-01 (Median) Methylation in Control 1.11E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg19653967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 8.43E-06; Z-score: -1.25E+00

Methylation in Case

6.96E-01 (Median) Methylation in Control 7.95E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg13971030)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 2.83E-04; Z-score: -7.63E-01

Methylation in Case

9.25E-01 (Median) Methylation in Control 9.33E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg19112204)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 1.83E-03; Z-score: -7.43E-01

Methylation in Case

8.16E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

Body (cg08411235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.06E+00 Statistic Test p-value: 4.86E-02; Z-score: 3.07E-01

Methylation in Case

5.42E-01 (Median) Methylation in Control 5.11E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 20

Methylation of SLC1A2 in colorectal cancer [ 6 ]

Location

3'UTR (cg26635576)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.44E-04; Z-score: -1.53E+00

Methylation in Case

9.24E-01 (Median) Methylation in Control 9.39E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         19 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg02577240)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.66E+00 Statistic Test p-value: 3.30E-17; Z-score: -3.58E+00

Methylation in Case

4.02E-01 (Median) Methylation in Control 6.68E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg16104584)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.45E+00 Statistic Test p-value: 2.39E-13; Z-score: -2.48E+00

Methylation in Case

2.48E-01 (Median) Methylation in Control 3.60E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg25963980)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.27E+00 Statistic Test p-value: 2.02E-04; Z-score: -1.28E+00

Methylation in Case

2.39E-01 (Median) Methylation in Control 3.03E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg10159951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 1.95E-03; Z-score: -8.49E-01

Methylation in Case

1.66E-01 (Median) Methylation in Control 2.12E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg08258650)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 1.72E-02; Z-score: -7.84E-01

Methylation in Case

1.23E-01 (Median) Methylation in Control 1.57E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS1500 (cg18494399)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 4.37E-02; Z-score: 3.99E-01

Methylation in Case

1.73E-01 (Median) Methylation in Control 1.50E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

TSS200 (cg07724977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.72E+00 Statistic Test p-value: 1.23E-05; Z-score: -1.21E+00

Methylation in Case

1.65E-01 (Median) Methylation in Control 2.83E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg14994247)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.55E+00 Statistic Test p-value: 1.87E-18; Z-score: -3.60E+00

Methylation in Case

3.14E-01 (Median) Methylation in Control 4.88E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg08411235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.34E+00 Statistic Test p-value: 4.63E-08; Z-score: -1.76E+00

Methylation in Case

4.12E-01 (Median) Methylation in Control 5.51E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg19653967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 2.81E-07; Z-score: -1.32E+00

Methylation in Case

5.04E-01 (Median) Methylation in Control 6.19E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg19112204)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.30E+00 Statistic Test p-value: 1.26E-05; Z-score: -1.27E+00

Methylation in Case

3.92E-01 (Median) Methylation in Control 5.11E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg10331829)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.35E-03; Z-score: -5.92E-01

Methylation in Case

8.10E-01 (Median) Methylation in Control 8.31E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.75E-03; Z-score: -7.83E-01

Methylation in Case

6.47E-01 (Median) Methylation in Control 6.94E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg21895324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 2.11E-03; Z-score: -1.25E-01

Methylation in Case

6.85E-01 (Median) Methylation in Control 6.95E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg20740024)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 5.37E-03; Z-score: -8.06E-01

Methylation in Case

8.52E-01 (Median) Methylation in Control 8.73E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg23501962)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.23E+00 Statistic Test p-value: 2.35E-02; Z-score: -8.56E-01

Methylation in Case

1.85E-01 (Median) Methylation in Control 2.28E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

Body (cg24183324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.41E+00 Statistic Test p-value: 3.40E-02; Z-score: -9.89E-01

Methylation in Case

1.46E-01 (Median) Methylation in Control 2.05E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

3'UTR (cg25475999)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 5.19E-04; Z-score: -6.69E-01

Methylation in Case

8.36E-01 (Median) Methylation in Control 8.56E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC1A2 in hepatocellular carcinoma [ 7 ]

Location

3'UTR (cg26635576)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 5.50E-04; Z-score: -1.13E+00

Methylation in Case

8.57E-01 (Median) Methylation in Control 8.81E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

         19 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS1500 (cg08258650)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.59E-04; Z-score: 7.89E-01

Methylation in Case

5.13E-02 (Median) Methylation in Control 4.32E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS1500 (cg10159951)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 3.65E-04; Z-score: 8.72E-01

Methylation in Case

5.98E-02 (Median) Methylation in Control 4.83E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS1500 (cg18494399)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.88E+00 Statistic Test p-value: 4.81E-04; Z-score: 1.78E+00

Methylation in Case

3.10E-02 (Median) Methylation in Control 1.65E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS1500 (cg15562780)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 1.12E-03; Z-score: 9.85E-01

Methylation in Case

9.31E-02 (Median) Methylation in Control 8.02E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS1500 (cg24634422)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.57E+00 Statistic Test p-value: 1.19E-03; Z-score: 1.68E+00

Methylation in Case

6.71E-02 (Median) Methylation in Control 4.26E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS1500 (cg21163960)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.18E+00 Statistic Test p-value: 2.70E-02; Z-score: 5.68E-01

Methylation in Case

4.76E-02 (Median) Methylation in Control 4.04E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

TSS200 (cg17754876)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.18E+00 Statistic Test p-value: 1.16E-03; Z-score: 1.12E+00

Methylation in Case

1.01E-01 (Median) Methylation in Control 8.58E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg08411235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 5.19E-11; Z-score: 1.56E+00

Methylation in Case

9.06E-01 (Median) Methylation in Control 8.66E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg13971030)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 5.61E-11; Z-score: 1.61E+00

Methylation in Case

9.11E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg21818891)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 6.53E-09; Z-score: -4.76E+00

Methylation in Case

6.64E-01 (Median) Methylation in Control 8.49E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg21895324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 3.10E-07; Z-score: -2.61E+00

Methylation in Case

7.78E-01 (Median) Methylation in Control 8.51E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg10331829)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.40E-05; Z-score: -1.57E+00

Methylation in Case

8.79E-01 (Median) Methylation in Control 9.13E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg25961618)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 2.27E-05; Z-score: -1.50E+00

Methylation in Case

7.48E-01 (Median) Methylation in Control 8.07E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg19653967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 3.56E-05; Z-score: 1.32E+00

Methylation in Case

6.79E-01 (Median) Methylation in Control 6.13E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg27457284)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.25E+00 Statistic Test p-value: 1.24E-04; Z-score: 8.99E-01

Methylation in Case

8.99E-02 (Median) Methylation in Control 7.17E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg24183324)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 7.87E-04; Z-score: 7.96E-01

Methylation in Case

1.35E-01 (Median) Methylation in Control 1.16E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg19112204)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.13E-02; Z-score: -7.22E-01

Methylation in Case

8.43E-01 (Median) Methylation in Control 8.58E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 2.75E-02; Z-score: -4.11E-01

Methylation in Case

8.86E-01 (Median) Methylation in Control 9.00E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC1A2 in HIV infection [ 8 ]

Location

Body (cg13844463)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.41E-02; Z-score: -2.18E-01

Methylation in Case

5.49E-01 (Median) Methylation in Control 5.61E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

TSS1500 (cg18494399)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 6.85E-04; Z-score: 7.34E-01

Methylation in Case

5.48E-02 (Median) Methylation in Control 4.88E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

TSS1500 (cg15562780)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 2.68E-02; Z-score: 4.21E-01

Methylation in Case

7.43E-02 (Median) Methylation in Control 6.92E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

TSS200 (cg07724977)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.04E+00 Statistic Test p-value: 3.50E-03; Z-score: 2.31E-01

Methylation in Case

6.26E-02 (Median) Methylation in Control 6.00E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

TSS200 (cg25230151)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 3.54E-02; Z-score: -2.51E-01

Methylation in Case

4.46E-02 (Median) Methylation in Control 4.75E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg21818891)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.94E-08; Z-score: -1.80E+00

Methylation in Case

8.23E-01 (Median) Methylation in Control 8.76E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg13844463)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 5.61E-07; Z-score: -1.03E+00

Methylation in Case

6.07E-01 (Median) Methylation in Control 6.73E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg25961618)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.95E-03; Z-score: -4.54E-01

Methylation in Case

7.74E-01 (Median) Methylation in Control 7.90E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg14746605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 3.56E-03; Z-score: 6.16E-01

Methylation in Case

6.84E-01 (Median) Methylation in Control 6.38E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.15E+00 Statistic Test p-value: 3.67E-03; Z-score: 9.56E-01

Methylation in Case

7.64E-01 (Median) Methylation in Control 6.65E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg20740024)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 1.07E-02; Z-score: 6.12E-01

Methylation in Case

8.87E-01 (Median) Methylation in Control 8.66E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC1A2 in papillary thyroid cancer [ 9 ]

Location

Body (cg23501962)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 4.64E-02; Z-score: -8.42E-01

Methylation in Case

1.77E-01 (Median) Methylation in Control 2.03E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in systemic lupus erythematosus [ 10 ]

Location

TSS1500 (cg25963980)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.75E-02; Z-score: -8.09E-02

Methylation in Case

2.42E-01 (Median) Methylation in Control 2.48E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg19653967)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.26E-02; Z-score: -2.06E-01

Methylation in Case

7.19E-01 (Median) Methylation in Control 7.35E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.34E-02; Z-score: -2.14E-01

Methylation in Case

8.60E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in systemic lupus erythematosus [ 10 ]

Location

Body (cg22934516)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 4.48E-02; Z-score: -1.00E-01

Methylation in Case

1.26E-01 (Median) Methylation in Control 1.31E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg04987335)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.12E-03; Z-score: -7.94E-01

Methylation in Case

8.49E-01 (Median) Methylation in Control 8.94E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg08411235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 6.21E-03; Z-score: 5.52E-01

Methylation in Case

8.69E-01 (Median) Methylation in Control 8.28E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg10331829)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.43E-02; Z-score: -4.97E-01

Methylation in Case

8.61E-01 (Median) Methylation in Control 8.88E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg13844463)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 3.93E-02; Z-score: -5.16E-01

Methylation in Case

1.40E-01 (Median) Methylation in Control 1.55E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

Body (cg13971030)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 4.04E-02; Z-score: -5.58E-01

Methylation in Case

2.59E-01 (Median) Methylation in Control 3.14E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

3'UTR (cg25475999)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 2.06E-09; Z-score: -1.63E+00

Methylation in Case

8.36E-01 (Median) Methylation in Control 9.04E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC1A2 in atypical teratoid rhabdoid tumor [ 11 ]

Location

3'UTR (cg26635576)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.57E+00 Statistic Test p-value: 3.04E-09; Z-score: 1.47E+00

Methylation in Case

4.79E-01 (Median) Methylation in Control 3.06E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Depression

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in depression [ 12 ]

Location

Body (cg13971030)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 4.43E-02; Z-score: 4.68E-01

Methylation in Case

6.75E-01 (Median) Methylation in Control 6.31E-01 (Median)

Studied Phenotype

Depression [ ICD-11: 6A8Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in lung adenocarcinoma [ 13 ]

Location

Body (cg13971030)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 3.72E-03; Z-score: 1.48E+00

Methylation in Case

7.95E-01 (Median) Methylation in Control 7.12E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in lung adenocarcinoma [ 13 ]

Location

Body (cg08411235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.28E+00 Statistic Test p-value: 5.73E-03; Z-score: 2.44E+00

Methylation in Case

6.61E-01 (Median) Methylation in Control 5.14E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in lung adenocarcinoma [ 13 ]

Location

Body (cg21818891)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 1.80E-02; Z-score: -3.27E+00

Methylation in Case

7.07E-01 (Median) Methylation in Control 7.98E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in panic disorder [ 14 ]

Location

Body (cg19112204)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 2.16E-02; Z-score: 2.38E-01

Methylation in Case

3.10E+00 (Median) Methylation in Control 3.00E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Prostate cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC1A2 in prostate cancer [ 15 ]

Location

Body (cg09243106)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 6.21E-03; Z-score: 2.40E+00

Methylation in Case

9.46E-01 (Median) Methylation in Control 8.99E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC1A2 in prostate cancer [ 15 ]

Location

Body (cg08737116)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.91E+00 Statistic Test p-value: 8.01E-03; Z-score: -2.66E+00

Methylation in Case

2.93E-01 (Median) Methylation in Control 5.59E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC1A2 in prostate cancer [ 15 ]

Location

Body (cg19503341)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 8.34E-03; Z-score: -3.13E+00

Methylation in Case

3.55E-01 (Median) Methylation in Control 4.73E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC1A2 in prostate cancer [ 15 ]

Location

Body (cg03107235)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.78E+00 Statistic Test p-value: 1.93E-02; Z-score: 3.04E+00

Methylation in Case

5.19E-01 (Median) Methylation in Control 2.91E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC1A2 in prostate cancer [ 15 ]

Location

Body (cg17330838)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.70E+00 Statistic Test p-value: 4.70E-02; Z-score: -2.42E+00

Methylation in Case

2.41E-01 (Median) Methylation in Control 4.10E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Nodular goiter

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypomethylation of SLC1A2 in nodular goiter [ 16 ]

Location

Promoter

Epigenetic Type

Methylation Experiment Method Methylation-specific PCR

Studied Phenotype

Nodular goiter [ ICD-11: 5A01.Z]

Experimental Material

Multiple cell lines of human; Patient tissue samples

Additional Notes

A distinct methylation profiling in drug metabolism and transport genes between nodular goiter and normal thyroid tissues, particularly ABCB4, CYP1B1 and CYP24A1 and SLC1A2.

  Hemangioblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC1A2 in hemangioblastoma than that in healthy individual

Studied Phenotype

Hemangioblastoma [ICD-11:2F7C]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.17E-12; Fold-change: 0.215642809; Z-score: 4.406871521
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Lymphoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC1A2 in lymphoma than that in healthy individual

Studied Phenotype

Lymphoma [ICD-11:2B30]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.30E-09; Fold-change: 0.410154074; Z-score: 11.24560094
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

microRNA

  Unclear Phenotype

         44 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-1273h directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-1273h miRNA Mature ID miR-1273h-5p

miRNA Sequence

CUGGGAGGUCAAGGCUGCAGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 2

miR-1324 directly targets SLC1A2 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-1324 miRNA Mature ID miR-1324

miRNA Sequence

CCAGACAGAAUUCUAUGCACUUUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 3

miR-149 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-149 miRNA Mature ID miR-149-3p

miRNA Sequence

AGGGAGGGACGGGGGCUGUGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 4

miR-15a directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-15a miRNA Mature ID miR-15a-3p

miRNA Sequence

CAGGCCAUAUUGUGCUGCCUCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 5

miR-1908 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-1908 miRNA Mature ID miR-1908-5p

miRNA Sequence

CGGCGGGGACGGCGAUUGGUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 6

miR-1910 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-1910 miRNA Mature ID miR-1910-5p

miRNA Sequence

CCAGUCCUGUGCCUGCCGCCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 7

miR-24 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-24 miRNA Mature ID miR-24-3p

miRNA Sequence

UGGCUCAGUUCAGCAGGAACAG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 8

miR-30a directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-30a miRNA Mature ID miR-30a-3p

miRNA Sequence

CUUUCAGUCGGAUGUUUGCAGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 9

miR-30b directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-30b miRNA Mature ID miR-30b-3p

miRNA Sequence

CUGGGAGGUGGAUGUUUACUUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 10

miR-30c-1 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-30c-1 miRNA Mature ID miR-30c-1-3p

miRNA Sequence

CUGGGAGAGGGUUGUUUACUCC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 11

miR-30c-2 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-30c-2 miRNA Mature ID miR-30c-2-3p

miRNA Sequence

CUGGGAGAAGGCUGUUUACUCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 12

miR-30d directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-30d miRNA Mature ID miR-30d-3p

miRNA Sequence

CUUUCAGUCAGAUGUUUGCUGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 13

miR-30e directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-30e miRNA Mature ID miR-30e-3p

miRNA Sequence

CUUUCAGUCGGAUGUUUACAGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 14

miR-3122 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3122 miRNA Mature ID miR-3122

miRNA Sequence

GUUGGGACAAGAGGACGGUCUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 15

miR-3176 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3176 miRNA Mature ID miR-3176

miRNA Sequence

ACUGGCCUGGGACUACCGG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 16

miR-3190 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3190 miRNA Mature ID miR-3190-5p

miRNA Sequence

UCUGGCCAGCUACGUCCCCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 17

miR-3689a directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3689a miRNA Mature ID miR-3689a-3p

miRNA Sequence

CUGGGAGGUGUGAUAUCGUGGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 18

miR-3689b directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3689b miRNA Mature ID miR-3689b-3p

miRNA Sequence

CUGGGAGGUGUGAUAUUGUGGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 19

miR-3689c directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3689c miRNA Mature ID miR-3689c

miRNA Sequence

CUGGGAGGUGUGAUAUUGUGGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 20

miR-383 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-383 miRNA Mature ID miR-383-3p

miRNA Sequence

ACAGCACUGCCUGGUCAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 21

miR-3913 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3913 miRNA Mature ID miR-3913-5p

miRNA Sequence

UUUGGGACUGAUCUUGAUGUCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 22

miR-3922 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-3922 miRNA Mature ID miR-3922-3p

miRNA Sequence

UCUGGCCUUGACUUGACUCUUU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 23

miR-4284 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4284 miRNA Mature ID miR-4284

miRNA Sequence

GGGCUCACAUCACCCCAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 24

miR-455 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-455 miRNA Mature ID miR-455-3p

miRNA Sequence

GCAGUCCAUGGGCAUAUACAC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 25

miR-4728 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4728 miRNA Mature ID miR-4728-5p

miRNA Sequence

UGGGAGGGGAGAGGCAGCAAGCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 26

miR-4743 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-4743 miRNA Mature ID miR-4743-5p

miRNA Sequence

UGGCCGGAUGGGACAGGAGGCAU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 27

miR-497 directly targets SLC1A2 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-497 miRNA Mature ID miR-497-3p

miRNA Sequence

CAAACCACACUGUGGUGUUAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 28

miR-500a directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-500a miRNA Mature ID miR-500a-5p

miRNA Sequence

UAAUCCUUGCUACCUGGGUGAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 29

miR-501 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-501 miRNA Mature ID miR-501-5p

miRNA Sequence

AAUCCUUUGUCCCUGGGUGAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 30

miR-548as directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-548as miRNA Mature ID miR-548as-3p

miRNA Sequence

UAAAACCCACAAUUAUGUUUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 31

miR-564 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-564 miRNA Mature ID miR-564

miRNA Sequence

AGGCACGGUGUCAGCAGGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 32

miR-6513 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6513 miRNA Mature ID miR-6513-5p

miRNA Sequence

UUUGGGAUUGACGCCACAUGUCU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 33

miR-663a directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-663a miRNA Mature ID miR-663a

miRNA Sequence

AGGCGGGGCGCCGCGGGACCGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 34

miR-6776 directly targets SLC1A2 [ 18 ]

Epigenetic Type

microRNA Experiment Method PAR-CLIP

miRNA Stemloop ID

miR-6776 miRNA Mature ID miR-6776-3p

miRNA Sequence

CAACCACCACUGUCUCUCCCCAG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 35

miR-6779 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6779 miRNA Mature ID miR-6779-5p

miRNA Sequence

CUGGGAGGGGCUGGGUUUGGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 36

miR-6780a directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6780a miRNA Mature ID miR-6780a-5p

miRNA Sequence

UUGGGAGGGAAGACAGCUGGAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 37

miR-6785 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6785 miRNA Mature ID miR-6785-5p

miRNA Sequence

UGGGAGGGCGUGGAUGAUGGUG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 38

miR-6787 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6787 miRNA Mature ID miR-6787-5p

miRNA Sequence

UGGCGGGGGUAGAGCUGGCUGC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 39

miR-6788 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6788 miRNA Mature ID miR-6788-5p

miRNA Sequence

CUGGGAGAAGAGUGGUGAAGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 40

miR-6799 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6799 miRNA Mature ID miR-6799-5p

miRNA Sequence

GGGGAGGUGUGCAGGGCUGG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 41

miR-6883 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-6883 miRNA Mature ID miR-6883-5p

miRNA Sequence

AGGGAGGGUGUGGUAUGGAUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 42

miR-7106 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-7106 miRNA Mature ID miR-7106-5p

miRNA Sequence

UGGGAGGAGGGGAUCUUGGG

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 43

miR-7977 directly targets SLC1A2 [ 19 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-7977 miRNA Mature ID miR-7977

miRNA Sequence

UUCCCAGCCAACGCACCA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon 44

miR-887 directly targets SLC1A2 [ 17 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-887 miRNA Mature ID miR-887-5p

miRNA Sequence

CUUGGGAGCCCUGUUAGACUC

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human
References
1 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
5 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
6 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
7 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
8 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
9 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
10 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
11 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
12 DNA methylation and inflammation marker profiles associated with a history of depression. Hum Mol Genet. 2018 Aug 15;27(16):2840-2850.
13 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
14 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
15 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
16 Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter. Thyroid Res. 2011 Oct 12;4(1):15.
17 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 2013 Jul 15;27(14):1624-32.
18 The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012 Jan;8(1):e1002484.
19 Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell. 2013 Jan 17;152(1-2):82-96.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.